Thyroid gland

From Libre Pathology
Revision as of 20:28, 17 January 2011 by Michael (talk | contribs) (→‎Benign: +solid cell nest)
Jump to navigation Jump to search

The thyroid gland is an important little endocrine organ in the anterior neck. It is not infrequently afflicted by cancer... but the common cancer has such a good prognosis there is debate about how aggressively it should be treated. The cytopathology of the thyroid gland is dealt with in the thyroid cytology article. It frustrates a significant number of pathologists, as the criteria for cancer are considered a bit wishy-washy.

Thyroid specimens

They come in 3 common varieties:

  • Hemithyroid.
    • Done to get a definitive diagnosis.
    • May be a "completion" - removal of the other half following definitive diagnosis.
  • Total thyroid.
    • Done for malignancy or follicular lesion.
  • FNA (fine needle aspiration).
    • done to r/o malignancy.

Gross pathology:

  • White nodules - think:
    • Lymphoid tissue.
    • Papillary thyroid carcinoma - may be calcified.[1]

Common diagnoses

  • Nodular hyperplasia.
  • Lymphocytic thyroiditis.
  • Papillary thyroid carcinoma -- most common cancer.
  • Follicular adenoma.
  • Follicular thryoid carcinoma.
  • Parathyroid tissue.

Parathyroid tissue

General:

  • Identification of normal can be tricky.

Features:[2]

  • Low power:
    • May vaguely resemble lymphoid tissue - may have hyperchromatic cytoplasm.
      • Does not have follicular centres like a lymph node.
    • May form gland-like structure and vaguely resemble the thyroid at low power.
    • Cytoplasm may be clear[3] - key feature.
    • Surrounded by a thin fibrous capsule.
  • High power:
    • Mixed cell population:[4]
      • Chief cells - predominant cell type, small, cytoplasm has variable staining (hyperchromatic-clear-eosinophilic).
      • Oxyphil cells (acid staining cells[5]) - abundant cytoplasm.
      • Adipocytes - increased with age, may be used to help differentiate from thyroid - key feature.


Name Staining (cytoplasm) Quantity of cells Cytoplasm (quantity) Function
(parathyroid) chief cells intense hyperchromatic to eosinophilic (see note) abundant moderate manufacture PTH
oxyphil cells moderate/light hyperchromatic to eosinophilic rare abundant ?

Notes:

  • Cytoplasmic staining varies considerably on H&E preparations - it may vary from hyperchromatic[6] to clear to eosinophilic[7].
  • Chief cells tend to stain more intensely than oxyphil cells.

Thyroid vs. parathyroid (see: parathyroid image):

  • Parathyroid cytoplasm:
    • Hyperchromatic.

Parathyroid vs. lymphoid tissue (see parathyroid image):

  • Parathyroid:
    • No germinal centres.
    • Gland-like/follicular-like arrangement -- much smaller than normal follicles of
    • Occasional cell with rim of clear cytoplasm (oxyphil?).

Images:

Parathyroid hyperplasia

  • Parathyroid hyperplasia - classically assoc. with renal failure.
  • Chief cell hyperplasia - associated with MEN I, MEN IIa.[8]

Parathryoid adenoma

  • One parathyroid is big... the others are small.
  • Associated with MEN I and MEN IIa/b (II/III).

MEN I:

MEN IIa/IIb (II/III):

Image: Parathyroid adenoma (med.utah.edu).[9]

Benign

Solid cell nest of thyroid

General

  • Embryonic remnants endodermal origin.[10]
  • Incidental finding.

Microscopic

Features:[10]

  • Solid or cystic cluster or variable size.
  • Cuboidal-to-columnar morphology.
  • Eosinophilic cytoplasm.
  • Round/ovoid nuclei with finely granular chromatin.
  • +/-Goblet cells (~30% of cases).[11]

Image:

DDx:[10]

  • C-cell hyperplasia.
  • Medullary carcinoma.
  • Squamous lesions.

IHC

Features:[10]

  • p63 +ve.
    • -ve in clear cells.
  • CEA +ve (polyconal).[11]
    • +ve also in clear cells.

Nodular hyperplasia

General

  • AKA goitre, AKA sporadic goitre, AKA multinodular goitre (MNG).
  • Most common diagnosis in the thyroid.
    • If you've seen a handful of thyroids you've seen this.

Notes:

  • Large lesions may be clonal; however, this is clinically irrelevant.

Microscopic

Features:

  • Follicles of variable size - key feature.
    • Should be obvious at low power, i.e. ~2.5x objective.
  • Nodules maybe well circumscribed (on gross), but do not have a thick fibrous capsule.

Negatives:

  • No nuclear features suggestive of malignancy (at lower power).
    • One should not look at high power.
  • Not cellular.

Follicular adenoma

  • Most common neoplasm of thyroid[12]
  • Encapusled lesion (surrounded by fibrous capsule).
  • Cellular.
  • Negatives
    • No nuclear features suggestive of papillary carcinoma.

Graves disease

  • Often misspelled "Grave's disease".
  • Hyperthyroidism.
  • Etiology: autoimmune.

Gross

Features:[13]

    • Enlarged 50-150 g.
    • "Beefy-red" appearance, looks like raw beef.

Microscopic

Features:

  • Papillae (may mimic papillary thyroid carcinoma in this respect).

Granulomatous thyoiditis

Features:[14]

  • AKA de Quervain disease.
  • Women > men.

Ridel thyroiditis

Hashimoto's thyroiditis

General

Presentation:

  • Hypothyroid

Associations:[15]

  • Antimicrosomal (antithyroid peroxidase) +ve.
  • Antithyroglobulin +ve.
  • Increased risk of B-cell lymphoma.

Etiology:

  • Autoimmune.
    • Often genetic/part of a syndrome.

Microscopic

Features:

  • Histologically often not possible to separate from "nonspecific" thyroiditis.[16]
  • Nuclear clearing common - ergo may confuse with papillary carcinoma.
  • Polymorphous lymphoplasmacytic infiltrate with germinal centres.[17]

Malignant neoplasm

There are a bunch of 'em. The most common, by far, is papillary.

Papillary

Clinical

Basic clinican knowledge - P's:

  • Palpable nodes.
  • Popular (most common malignant neoplasm of the thyroid).
  • Prognosis is good.
  • Pre-Tx iodine scan.
  • Post-Sx iodine scan.
  • Psammoma bodies.

Notes:

  • Associated with radiation exposure.[18]

Microscopic

Features:

  • Nuclear changes - key feature.
    • "Shrivelled nuclei"/"raisin" like nuclei, nuclei with a wavy nuclear membrane.
    • Nuclear grooves.
    • Nuclear inclusions.
    • Nuclear clearing (only on permanent section) - also known as "Orphan Annie eyes".
  • Overlap of nuclei - "cells do not respect each other's borders" (easy to see at key feature at low power).
  • Classically has papillae (nipple-like shape).
    • Absence of papillae does not exclude diagnosis.
  • Psammoma bodies.
    • Circular, acellular, eosinophilic whorled bodies.
    • Not necessary to make diagnosis.
    • Arise from infarction & calcification of papilla tips.[19]

Notes:

  • Psammoma bodies are awesome if you see 'em, i.e. useful for arriving at the diagnosis.
    • If there are no papillae structures -- you're unlikely to see psammomas.
  • At low power look for cellular areas/loss of follicles.
  • Nuclear clearing seen in:
    • Hashimoto's and papillary thyroid carcinoma.[20]
    • May be an artifact of fixation/processing.
  • Nuclear overlapping is easy to see at lower power-- should be the tip-off to look at high power for nuclear features.
  • Nuclear inclusions are quite rare and not required to make the diagnosis -- but a very convincing feature if seen.
  • Papillae may be seen in Graves disease.

Subtypes if papillary

There are many.

Tall cell variant

Features:[21]

  • 50% of cells with height 2x the width.[22][23]
    • There is some disagreement on these criteria.[23]
  • Eosinophilic cytoplasm.
  • Well-defined cell borders.
  • Nucleus stratified; basal location, i.e. closer to the basement membrane.

Negative:

  • Nuclei not pseudostratified, if pseudostratified consider columnar cell variant.

Columnar cell variant

Epidemiology:

  • Poor prognosis.

Features:

  • Elongated nuclei (similar to colorectal adenocarcinoma) - key feature.
  • Pseudostratification of the nuclei (like in colorectal adenocarcinoma), differentiates from tall cell variant - key feature.
  • "Minimal" papillary features.
  • "Tall cells".
  • Clear-eosinophilic cytoplasm.
  • Mitoses common.

Image: Tall cell variant Pa ca (wiley.com).

Follicular variant

May be confused with follicular carcinoma or follicular adenoma.

Features:

  • Prominent follicles.

Cribriform-morular variant

Features:

  • Cribriform pattern.
  • Morules - balls of tissue.

Insular carcinoma

General:[24]

  • Rare - approximately 5% of all thyroid carcinomas.
  • Thought to be a separate tumour from papillary thyroid carcinoma and follicular thyroid carcinoma with a focal insular pattern.
  • Some lump this entity with papillary carcinoma, i.e. consider it a variant of papillary thyroid carcinoma.

Features:[24]

  • Islands of cells - key feature.
  • Scant cytoplasm.
  • Nuclei monomorphic and round.

DDx:[25]

  • Medullary thyroid carcinoma.
  • Poorly differentiated thyroid carcinoma.

Follicular thyroid carcinoma

Clinical

  • FNA NOT diagnosable.
  • Far away mets (sometimes).
  • Female predominant.
  • Favourable prognosis.

Microscopic

Features:

  • IMPOSSIBLE to differentiate from follicular adenoma on FNA (no cytologic differences).
  • Defined by invasion through the capsule.

Medullary thyroid carcinoma

General

  • Abbreviated MTC.

Medical school memory device - 3 M's:

Epidemiology:

  • Very rare.
  • Poor prognosis.
  • May be genetic (MEN IIa/b syndrome).
  • Arises from C cells (which produce calcitonin).

Microscopic

Features:

  • Nuclei with "neuroendocrine features".
    • Small, round nuclei.
    • Coarse chromatin (salt and pepper nuclei).
  • Amyloid deposits - fluffy appearing acellular eosinophilic material in the cytoplasm.
  • C-cell hyperplasia (associated with familial forms of MTC).
    • C cells (AKA parafollicular cell): abundant cytoplasm - clear/pale.

IHC:[26]

  • Calcitonin +ve - it arises from C cells (which produce calcitonin).
  • Congo-red +ve (amyloid present) - mnemonic: CRAP -- congo red amyloid protein.
  • Neuroendocrine markers.
  • CEA +ve (often better staining than calcitonin).[27]

Image:

Anaplastic thyroid carcinoma

Epidemiology

  • Very rare.
  • Horrible prognosis.

Microscopic

Features:

  • Cytologically malignant:

Image: Anaplastic thyroid carcinoma with a component of papillary thyroid carcinoma (WC).

IHC

  • Keratin (AE1/AE3).
  • Vimentin +ve, >90%.[28]
  • Thyroglobulin - rarely +ve (~15%).[28]
  • CEA -ve, calcitonin -ve; to r/o medullary.

Thyroid IHC - general comments

  • Not really useful.
  • Papers with very small sample sizes abound.

Follicular thyroid carcinoma vs. papillary thyroid carcinoma

  • CD31 more frequently positive in follicular lesions.[29]
    • CD31 is a marker for microvessel density.
  • Galectin-3 thought to be positive in papillary carcinoma.[29]
  • HBME-1 thought to be positive in papillary lesions.[30]

See also

References

  1. ↑ BEC. 20 October 2009.
  2. ↑ http://www.medicalhistology.us/twiki/pub/Main/ChapterFourteenSlides/b56b_parathyroid_40x_he_labeled.jpg
  3. ↑ http://pathology.mc.duke.edu/research/Histo_course/parathyroid2.jpg
  4. ↑ http://www.bu.edu/histology/p/15002loa.htm
  5. ↑ http://dictionary.reference.com/search?q=oxyphil%20cell
  6. ↑ http://www.deltagen.com/target/histologyatlas/atlas_files/endocrine/parathyroid_and_thyroid_glands_20x.jpg
  7. ↑ http://instruction.cvhs.okstate.edu/Histology/HistologyReference/hrendo.htm
  8. ↑ URL: http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970475-2. Accessed on: 29 July 2010.
  9. ↑ URL: http://library.med.utah.edu/WebPath/EXAM/IMGQUIZ/enfrm.html. Accessed on: 6 December 2010.
  10. ↑ 10.0 10.1 10.2 10.3 Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simões M (January 2003). "p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin". Mod. Pathol. 16 (1): 43–8. doi:10.1097/01.MP.0000047306.72278.39. PMID 12527712. http://www.nature.com/modpathol/journal/v16/n1/full/3880708a.html.
  11. ↑ 11.0 11.1 Mizukami Y, Nonomura A, Michigishi T, et al. (February 1994). "Solid cell nests of the thyroid. A histologic and immunohistochemical study". Am. J. Clin. Pathol. 101 (2): 186–91. PMID 7509563.
  12. ↑ Thompson, Lester D. R. (2006). Endocrine Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 51. ISBN 978-0443066856.
  13. ↑ Thompson, Lester D. R. (2006). Endocrine Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 30. ISBN 978-0443066856.
  14. ↑ Mills, Stacey E; Carter, Darryl; Greenson, Joel K; Oberman, Harold A; Reuter, Victor E (2004). Sternberg's Diagnostic Surgical Pathology (4th ed.). Lippincott Williams & Wilkins. pp. 559. ISBN 978-0781740517.
  15. ↑ Poropatich C, Marcus D, Oertel YC (1994). "Hashimoto's thyroiditis: fine-needle aspirations of 50 asymptomatic cases". Diagn. Cytopathol. 11 (2): 141–5. PMID 7813361. http://www3.interscience.wiley.com/journal/112701408/abstract?CRETRY=1&SRETRY=0.
  16. ↑ Mills, Stacey E; Carter, Darryl; Greenson, Joel K; Oberman, Harold A; Reuter, Victor E (2004). Sternberg's Diagnostic Surgical Pathology (4th ed.). Lippincott Williams & Wilkins. pp. 560. ISBN 978-0781740517.
  17. ↑ Lefkowitch, Jay H. (2006). Anatomic Pathology Board Review (1st ed.). Saunders. pp. 672. ISBN 978-1416025887.
  18. ↑ Mills, Stacey E; Carter, Darryl; Greenson, Joel K; Oberman, Harold A; Reuter, Victor E (2004). Sternberg's Diagnostic Surgical Pathology (4th ed.). Lippincott Williams & Wilkins. pp. 564. ISBN 978-0781740517.
  19. ↑ Mills, Stacey E; Carter, Darryl; Greenson, Joel K; Oberman, Harold A; Reuter, Victor E (2004). Sternberg's Diagnostic Surgical Pathology (4th ed.). Lippincott Williams & Wilkins. pp. 565. ISBN 978-0781740517.
  20. ↑ Mills, Stacey E; Carter, Darryl; Greenson, Joel K; Oberman, Harold A; Reuter, Victor E (2004). Sternberg's Diagnostic Surgical Pathology (4th ed.). Lippincott Williams & Wilkins. pp. 566. ISBN 978-0781740517.
  21. ↑ Urano M, Kiriyama Y, Takakuwa Y, Kuroda M (April 2009). "Tall cell variant of papillary thyroid carcinoma: Its characteristic features demonstrated by fine-needle aspiration cytology and immunohistochemical study". Diagn. Cytopathol.. doi:10.1002/dc.21086. PMID 19373912.
  22. ↑ http://pathologyoutlines.com/thyroid.html#tallcellvariant
  23. ↑ 23.0 23.1 Ghossein R, Livolsi VA (November 2008). "Papillary thyroid carcinoma tall cell variant". Thyroid 18 (11): 1179–81. doi:10.1089/thy.2008.0164. PMID 18925842.
  24. ↑ 24.0 24.1 Rufini V, Salvatori M, Fadda G, et al. (September 2007). "Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns". Cancer 110 (6): 1209–17. doi:10.1002/cncr.22913. PMID 17665497.
  25. ↑ Endo. fellow. 17 September 2009.
  26. ↑ http://pathologyoutlines.com/thyroid.html#medullary
  27. ↑ SB. 7 January 2010.
  28. ↑ 28.0 28.1 Ordóñez NG, El-Naggar AK, Hickey RC, Samaan NA (July 1991). "Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases". Am. J. Clin. Pathol. 96 (1): 15–24. PMID 1712540.
  29. ↑ 29.0 29.1 Rydlova, M.; Ludvikova, M.; Stankova, I. (Jun 2008). "Potential diagnostic markers in nodular lesions of the thyroid gland: an immunohistochemical study.". Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152 (1): 53-9. PMID 18795075.
  30. ↑ Papotti, M.; Rodriguez, J.; De Pompa, R.; Bartolazzi, A.; Rosai, J. (Apr 2005). "Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential.". Mod Pathol 18 (4): 541-6. doi:10.1038/modpathol.3800321. PMID 15529186.
Retrieved from "https://librepathology.org/w/index.php?title=Thyroid_gland&oldid=3674"